Pausa pranzo - Società italiana di neurologia
Pausa pranzo - Società italiana di neurologia
Pausa pranzo - Società italiana di neurologia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
25<br />
O<br />
T<br />
T<br />
O<br />
B<br />
R<br />
E<br />
•<br />
A<br />
R<br />
E<br />
A<br />
P<br />
O<br />
S<br />
T<br />
E<br />
R<br />
408. PREDICTIVE ROLE OF CEREBROSPINAL FLUID NEUROFILAMENT LIGHT<br />
CHAIN AND N-ACETYL ASPARTATE IN MULTIPLE SCLEROSIS DIAGNOSIS<br />
V. DIRENZO, C. TORTORELLA, P. IAFFALDANO, M. RUGGIERI, M. MASTRAPASQUA, R.<br />
VITERBO, D. PAOLICELLI, M. TROJANO (Bari)<br />
409. VERBAL FLUENCY DEFICITS IN PATIENTS WITH CLINICALLY ISOLATED<br />
SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS<br />
R. G. VITERBO, P. IAFFALDANO, V. DIRENZO, M. D'ONGHIA, D. PAOLICELLI, M.<br />
TROJANO (Bari)<br />
410. PREVALENCE OF FATIGUE AND ITS DETERMINANTS IN PATIENTS<br />
WITH MULTIPLE SCLEROSIS<br />
M. ROSSI, B. MACCARONE, C. RAPRELLI, A. CAROLEI, R. TOTARO (L’Aquila)<br />
411. LEUKAEMIA RELATED TO MTX THERAPY IN MS PATIENTS: MORTALITY<br />
RATE AND RELATIONSHIP WITH THE MTX LIFETIME CUMULATIVE<br />
DOSE<br />
E. PEREGO, L. STRAFFI, G. COMI, V. MARTINELLI (Milano)<br />
412. NATALIZUMAB THERAPY OF RELAPSING-REMITTING MULTIPLE<br />
SCLEROSIS: AN EVALUATION OF THE SAFETY PROFILE AND A<br />
COMPARISON OF EFFICACY WITH INTERFERON BETA THERAPY<br />
S. REALMUTO, G. SALEMI, F. CARDINALE, P. RAGONESE, V. CUSUMANO, V. LO RE,<br />
M. MAZZOLA, L. ZUMMO, P. CONALDI, G. SAVETTIERI (Palermo)<br />
413. INTERDISCIPLINARY APPROACH IMPROVES DISABILITY AND<br />
FUNCTIONAL OUTCOME IN MULTIPLE SCLEROSIS<br />
B. CICCONE, C. CRISCI, G. GRISO, P. VIVO, G. ESPEDITO, M. ANNUNZIATA, G.<br />
D'AVINO, K. DI COSTANZO, G. LOMBARDI, V. MENICHINI, A. PENNACCHIO, L.<br />
TACCONE (Marigliano - NA, Aversa - CE)<br />
414. COPING STRATEGIES IN THE EARLY STAGE OF MULTIPLE SCLEROSIS:<br />
A 24-MONTH FOLLOW-UP STUDY<br />
V. BIANCHI, L. PROSPERINI, V. BARLETTA, L. AUSILI-CEFARO, G. BORRIELLO, C.<br />
POZZILLI (Roma)<br />
415. INITIATION OF GLATIRAMER ACETATE TREATMENT FOLLOWED BY<br />
A SEVERE NEUROMYELITIS OPTICA RELAPSE: COINCIDENTAL OR<br />
CAUSAL<br />
D. FERRARO, A. SIMONE, E. MERELLI, P. NICHELLI, P. SOLA (Modena)<br />
416. SHORT-TERM TREATMENT WITH LOW DOSE NALTREXONE IS SAFE<br />
AND WELL TOLERATED IN PATIENTS WITH MULTIPLE SCLEROSIS: A<br />
SIX-MONTH FOLLOW-UP<br />
G. MOSCATO, F. MANFREDONIA, T. BOCCI, G. GAMBACCINI, M. VIRGILI, R. GALLI<br />
(Pontedera - PI, Pisa)<br />
417. IMMUNOMODULATION WITH MESENCHYMAL STEM CELLS IN A<br />
HUMANIZED T CELL RECEPTOR TRANSGENIC MODEL OF MULTIPLE<br />
SCLEROSIS<br />
F. GRASSIVARO, D. LOWTHER, F. VIANELLO, F. DAZZI, D. ALTMANN (Padova,<br />
London - UK)<br />
418. AQUAPORIN-4 IGG SEROPOSITIVE MYELITIS: EXTENT AND VARIABILITY<br />
IN SPINAL INVOLVEMENT<br />
M. CADALDINI, B. BONETTI, N. FREDDI, S. GUZZON, L. PADOVAN, B. PERIN, A.<br />
POLO (Monselice - PD, Verona)<br />
419. IS THE MSFC A SENSITIVE SCALE IN CIS AND MS FOLLOW UP IN AFTER<br />
TWO YEARS<br />
L. MOTTI, C. FEO, S. MONTEPIETRA, G E.RO.N.I.MU.S. (Reggio Emilia)<br />
176
Change language